Automated Pain Intervention for Underserved Minority Breast Cancer Patients
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Objective 1: To pilot test the efficacy of the interactive voice response (IVR) intervention for improving pain management and quality of life of underserved minority patients with breast cancer, as compared to the current standard of care.
Objective 2: To pilot test the efficacy of the IVR intervention for improving pain-related symptoms (fatigue, sleep disturbance, sadness) of underserved minority patients with breast cancer, as compared to the current standard of care.
Objective 3 (Secondary): To evaluate the feasibility of an IVR intervention for pain management that targets both underserved minority patients with breast cancer and their health care providers.
| Condition | Intervention |
|---|---|
|
Breast Cancer |
Behavioral: Telephone Intervention Behavioral: Questionnaires |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Automated Pain Intervention for Underserved Minority Breast Cancer Patients |
- MDASI IVR Patient Symptom Assessment [ Time Frame: Twice weekly ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 60 |
| Study Start Date: | February 2009 |
| Estimated Primary Completion Date: | February 2015 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| Telephone Intervention |
Behavioral: Telephone Intervention
Automated Telephone Interactive Voice Response (IVR) system taking approximately 5 minutes, 2 times week for 10 weeks, to rate pain and symptoms.
Behavioral: Questionnaires
Surveys approximately 1 hour each at 2 regularly scheduled clinic visits to rate pain and symptoms. Regardless of group, all symptoms are to be reported.
|
| Usual Care |
Behavioral: Questionnaires
Surveys approximately 1 hour each at 2 regularly scheduled clinic visits to rate pain and symptoms. Regardless of group, all symptoms are to be reported.
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Disadvantaged African American or Hispanic females diagnosed with breast cancer aged 18 years or older with access to telephones.
Inclusion Criteria:
- Diagnosis of breast cancer
- African American or Hispanic female
- Receiving treatment at LBJ General Hospital, Ben Taub Hospital, or M.D. Anderson Cancer Center
- Socioeconomically disadvantaged, as indicated by hospital billing code
- 18 years of age or older
- Living in the United States
- Speaks English or Spanish
- "Pain worst" score of 4 or greater on the Brief Pain Inventory
Exclusion Criteria:
- Current diagnosis of psychosis or dementia
- No access to telephones
- Unable to use the IVR system due to physical limitations (e.g., hearing impairment)
Contacts and Locations| United States, Texas | |
| UT MD Anderson Cancer Center | |
| Houston, Texas, United States, 77030 | |
| Principal Investigator: | Karen O. Anderson, PHD, MS, BA | UT MD Anderson Cancer Center |
More Information
Additional Information:
No publications provided
| Responsible Party: | M.D. Anderson Cancer Center |
| ClinicalTrials.gov Identifier: | NCT00881010 History of Changes |
| Other Study ID Numbers: | 2005-0380 |
| Study First Received: | April 13, 2009 |
| Last Updated: | February 12, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by M.D. Anderson Cancer Center:
|
Breast Cancer Pain Intervention Underserved minority patients African American |
Hispanic Automated Telephone System for measuring symptoms Interactive voice response IVR |
Additional relevant MeSH terms:
|
Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases |
ClinicalTrials.gov processed this record on June 17, 2013